GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WELL Health Technologies Corp (TSX:WELL) » Definitions » Debt-to-EBITDA

WELL Health Technologies (TSX:WELL) Debt-to-EBITDA : -5.00 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is WELL Health Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

WELL Health Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$28.0 Mil. WELL Health Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was C$397.1 Mil. WELL Health Technologies's annualized EBITDA for the quarter that ended in Dec. 2024 was C$-85.0 Mil. WELL Health Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was -5.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for WELL Health Technologies's Debt-to-EBITDA or its related term are showing as below:

TSX:WELL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -36.88   Med: 1.77   Max: 19.14
Current: 3.64

During the past 13 years, the highest Debt-to-EBITDA Ratio of WELL Health Technologies was 19.14. The lowest was -36.88. And the median was 1.77.

TSX:WELL's Debt-to-EBITDA is ranked worse than
63.82% of 456 companies
in the Healthcare Providers & Services industry
Industry Median: 2.38 vs TSX:WELL: 3.64

WELL Health Technologies Debt-to-EBITDA Historical Data

The historical data trend for WELL Health Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WELL Health Technologies Debt-to-EBITDA Chart

WELL Health Technologies Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -36.88 19.14 3.77 3.82 3.64

WELL Health Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 2.41 0.74 -2.05 -5.00

Competitive Comparison of WELL Health Technologies's Debt-to-EBITDA

For the Medical Care Facilities subindustry, WELL Health Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WELL Health Technologies's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where WELL Health Technologies's Debt-to-EBITDA falls into.


;
;

WELL Health Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

WELL Health Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(28.035 + 397.054) / 116.803
=3.64

WELL Health Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(28.035 + 397.054) / -85.02
=-5.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


WELL Health Technologies  (TSX:WELL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


WELL Health Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of WELL Health Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


WELL Health Technologies Business Description

Traded in Other Exchanges
Address
375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.
Executives
Eva Fong Senior Officer
Hamed Shahbazi 10% Security Holder, Director, Senior Officer
John Kim Director
Amir Javidan Senior Officer
Thomas Craig Liston Director
Tara Mccarville Director
Kenneth Anthony Cawkell Director
Sybil E Jen Lau Director
Well Health Technologies Corp. Issuer
Arjun Kumar Senior Officer
Brian Eric Levinkind Director